← Back to Clinical Trials
Recruiting NCT07080788

NCT07080788 Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07080788
Status Recruiting
Phase —
Sponsor University of Oklahoma
Condition Smoking Cessation Intervention
Study Type INTERVENTIONAL
Enrollment 150 participants
Start Date 2025-09-01
Primary Completion 2027-06

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Smoking Cessation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 150 participants in total. It began in 2025-09-01 with a primary completion date of 2027-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this pilot study is to assess whether 4-weeks of verified smoking abstinence following financial incentive treatment for smoking cessation improves physiological markers of chronic pain risk in adult Native American smokers. The main aims to answer are: 1. Determine study feasibility. 2. Obtain effect sizes for changes in pain amplification and pain inhibition in abstinent vs non-abstinent Native Americans. 3. Obtain effect sizes for variables in the conceptual model of the Native American smoking-pain relationship.

Eligibility Criteria

Inclusion Criteria: * Self-identify as Native American/American Indian * Currently daily smoker * Own a smartphone with a data plan * Ability to speak and read English Exclusion Criteria: * \>18 years of age * Currently pregnant * Self-reported history of heart disease or heart attack * Angina, arrhythmias, hypertension, heart disease * Current chronic pain * Pepper allergy * Inability to speak English * Current psychosis (assessed by Psychosis Screening Questionnaire) * Serious cognitive impairment (assessed by \<20 score on the Montreal Cognitive Assessment \[MoCA\])

Contact & Investigator

Central Contact

PLAN Lab

✉ tulsa.plan@gmail.com

📞 918-660-3048

Principal Investigator

Jamie L Rhudy, PhD

PRINCIPAL INVESTIGATOR

University of Oklahoma Health Sciences

Frequently Asked Questions

Who can join the NCT07080788 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Smoking Cessation Intervention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07080788 currently recruiting?

Yes, NCT07080788 is actively recruiting participants. Contact the research team at tulsa.plan@gmail.com for enrollment information.

Where is the NCT07080788 trial being conducted?

This trial is being conducted at Tulsa, United States.

Who is sponsoring the NCT07080788 clinical trial?

NCT07080788 is sponsored by University of Oklahoma. The principal investigator is Jamie L Rhudy, PhD at University of Oklahoma Health Sciences. The trial plans to enroll 150 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology